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Abstract
The antibiotic susceptibility profile was evaluated in 71 Enterobacteriaceae isolates obtained from
outpatient urine cultures in July 2010 from two health institutions in Santa Fe, Argentina. The highest
rates of antibiotic resistance were observed for ampicillin (AMP) (69%), trimethoprim/sulfametho-
xazole (TMS) (33%), and ciprofloxacin (CIP) (25%). Meanwhile, 21% of the isolates were resistant
to three or more tested antibiotics families. Thirty integron-containing bacteria (42.3%) were de-
tected, and a strong association with TMS resistance was found. Third generation cephalosporin re-
sistance was detected in only one Escherichia coli isolate, and it was characterized as a blaCMY-2
carrier. No plasmid-mediated quinolone resistance (PMQR) was found. Resistance to fluoroquino-
lone in the isolates was due to alterations in QRDR regions. Two mutations in GyrA (S83L, D87N)
and one in ParC (S80I) were observed in all CIP-resistant E. coli. It was determined to be the main
phylogenetic groups in E. coli isolates. Minimum Inhibitory Concentration (MIC) values against
nalidixic acid (NAL), levofloxacin (LEV), and CIP were determined for 63 uropathogenic E. coli iso-
lates as MIC50 of 4 g/mL, 0.03125 g/mL, and 0.03125 g/mL, respectively, while the MIC90 val-
ues of the antibiotics were determined as 1024 g/mL, 64 g/mL, and 16 g/mL, respectively. An
association between the phylogenetic groups, A and B1 with fluoroquinolone resistance was ob-
served. These results point to the importance of awareness of the potential risk associated with empir-
ical treatment with both the families of antibiotics.
Key words: urine tract infection, outpatient, -lactam resistance, fluoroquinolone resistance, inte-
grons.
Introduction
Urinary tract infections (UTIs) are the second most
common cause of human infections, next to respiratory
tract infections (Foxman, 2003). In Argentina, UTIs are the
most frequent reasons behind an outpatient medical consul-
tation. Furthermore, 95% of UTIs are caused by a single
microbial species, Escherichia coli, which is a main etio-
logic agent; while other species such as Klebsiella spp. and
Proteus spp. have also been reported occasionally (Auer et
al., 2010). Among E. coli, four major phylogenetic groups
(A, B1, B2, and D) have been identified as causal agents of
extra-intestinal infections. Usually, commensal strains
belong to A and B1 groups and contain low number of viru-
lence determinants, while extra-intestinal pathogenic
strains belong mainly to B2 group and to a lesser extent to D
group and contain genes encoding virulence factors respon-
sible for promoting colonization, adhesion, invasion, and
evasion of the defense mechanisms of the human host
(Clermont et al., 2000).
Currently, most antibiotic treatments for UTIs are
empirical, particularly for those acquired in the commu-
nity. In general, most of the prescribed antimicrobial agents
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belong to -lactams or fluoroquinolones groups (Aypak et
al., 2009). Most widely used -lactams include amino-
penicillins (ampicillin) and first-generation cephalosporins
(cephalothin and cephalexin), while new generation cepha-
losporins may be considered as reserve antibiotics. The
production of -lactamases is the key mechanism of resis-
tance to -lactam antibiotics in gram-negative bacilli (Gut-
kind et al., 2013).
On the other hand, ciprofloxacin and norfloxacin are
the fluoroquinolones commonly prescribed for treatment of
UTIs. Different chromosomally encoded mechanisms of
quinolone resistance have been established, viz. mutations
in quinolone resistance determining regions (QRDR) of
gyrA and parC genes and decreased accumulation of the
drug due to impermeability of the outer membrane and/or
over-expression of efflux pump systems (Ruiz, 2003). Fur-
thermore, plasmid-mediated quinolone resistance (PMQR)
genes have recently been described in Enterobacteriaceae
species, including qnr genes (qnrA, qnrB, qnrS, qnrC, and
qnrD), the modified acetyltransferase aac(6’)-Ib-cr, and
the efflux pumps qepA and oqxAB (Andres et al., 2013).
Most of these determinants could be associated with resis-
tance integrons which may be embedded in elements re-
lated to horizontal gene transfer (HGT). Resistance
integrons (or mobile integrons) are elements that contain
genetic determinants of the components of a system for
site-specific recombination that recognizes and captures re-
sistance genes in mobile cassettes (Di Conza and Gutkind
2010). Class 1, 2, and 3 integrons are widely associated
with resistance determinants in human clinical isolates
(Boucher et al., 2007).
The aim of this study was to determine the antibiotic
susceptibility profile in Enterobacteriaceae isolated from
outpatient urine cultures and evaluate their association with
the presence of resistance integrons. In addition, third-
generation cephalosporins and quinolones resistance deter-
minants were characterized, and phylogenetic group of E.
coli isolates was determined.
Materials and Methods
The study was carried out in Santa Fe city in July
2010. A total of 260 urine cultures from outpatients with
symptoms of UTIs were included in this report. Etiologic
agents were found in 85 out of 260 (33%) samples, and 71
out of 78 (91%) gram-negative bacilli were Enterobac-
teriaceae isolates, which have been included in this study.
The isolates were identified using conventional bio-
chemical and physiological tests. The antibiotic suscepti-
bility profile was determined by disk diffusion according to
CLSI guidelines (CLSI 2010) and Sociedad Argentina de
Bacteriología, Micología y Parasitología Clínica
(SADEBAC) recommendations (Famiglietti et al., 2005).
The antibiotics tested were ampicillin (AMP), ampicil-
lin/sulbactam (AMS), cephalothin (CTN), third-generation
cephalosporins (3GC) as cefotaxime (CTX), ceftazidime
(CAZ), and other antibiotics such as gentamicin (GEN),
ciprofloxacin (CIP), nitrofurantoin (NIT), and trimetho-
prim/sulfamethoxazole (TMS). The minimum inhibitory
concentration (MIC) of nalidixic acid (NAL), levofloxacin
(LEV), and CIP was determined by agar dilution method as
recommended by CLSI guideline (CLSI 2010).
Phenotypic identification of extended spectrum
(ESBL) and AmpC -lactamases were performed in those
isolates that showed resistance to 3GC by synergy tests us-
ing CTX and CAZ and compared with CTX/clavulanic acid
and CAZ/clavulanic acid-containing disks (CLSI 2010) or
with phenylboronic acid disks (Britania Lab, Argentina)
(Yagi et al., 2005), respectively.
The presence of class 1, 2, and 3 integrons, unusual
class 1 integrons, PMQR (qnrA, qnrB, qnrS, qnrC, qnrD,
qepA, and aac(6’)-Ib-cr), and -lactamases (blaDHA and
blaCMY for AmpC) genes were studied by PCR using spe-
cific primers (Table 1). The confirmation of aac(6’)-Ib-cr
variant was performed by RFLP-PCR using BseG I enzyme
(Fermentas, Thermo Fisher Scientific Inc., Massachusetts,
USA) and sequencing (Rincón et al., 2013). The presence
of mutations in the QRDR regions was studied in fluoro-
quinolone-resistant E. coli by amplification and sequencing
of gyrA and parC genes (Rodríguez-Martínez et al., 2006).
Finally, the phylogenetic group of all E. coli isolates
was determined by PCR according to the method described
by Clermont et.al. 2000.
Results
Out of all Enterobacteriaceae recovered (n = 71), 63
were identified as E. coli (88%), 6 as K. pneumoniae (9%)
and 2 as P. mirabilis (3%).
The antibiotic susceptibility profile of 71 isolates
studied is summarized in Table 2. It should be emphasized
that 15 (21%) isolates were resistant to three or more tested
antibiotics groups.
This study showed that 30 (42%) isolates were carry-
ing integrons. Of these 30 isolates, 23 had class 1 integrons
(77%), one had class 1 unusual integron (positive orf513),
and 9 (30%) had class 2 integrons, highlighting the fact that
two of E. coli isolates (6.7%) shared both classes of
integrons. None of the isolates were found to contain class 3
integrons. Fisher’s exact test failed to find any association
between the presence of integrons and resistance to AMP,
AMS, CTN, CTX, CAZ, GEN, CIP, or NIT (p > 0.05).
However, a strong association between resistance to TMS
and the presence of integrons (p = 0.0003) was observed.
Only one E. coli isolate was both CTX and CAZ resis-
tant and showed synergistic effect between 3GC and phe-
nylboronic acid suggesting the presence of AmpC -lacta-
mase. This isolate belonged to the phylogenetic group B1.
PCR and subsequent sequencing revealed that this isolate
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carried the blaCMY-2 gene (a plasmid AmpC enzyme,
AmpCp).
The search for PMQR determinants ruled out the
presence of qnr genes, qepA efflux pump, and allelic vari-
ant aac(6’)-Ib-cr over all of the isolates analyzed. Only ac-
etylating variant, aac(6’)-Ib with activity towards amino-
glycosides was found in 5 of 71 isolates (3 K. pneumoniae
and 2 E. coli). MIC50 values to NAL, LEV, and CIP, deter-
mined for the 63 uropathogenic E. coli isolates, were
4 g/mL, 0.03125 g/mL, and 0.03125 g/mL, respec-
tively; while the MIC90 values for the same antibiotics were
1024 g/mL, 64 g/mL, and 16 g/mL, respectively.
The absence of PMQR in these isolates makes one to
suspect that fluoroquinolone resistance in these isolates
was due to mutations in the QRDR regions. As expected, all
fluoroquinolone-resistant E. coli (n = 13) have been found
to contain two mutations in the gyrA sequence (Ser83Leu
and Asp87Asn) and at least one in parC (Ser80Ile). A sin-
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Table 1 - PCR primers used to detect integrons or resistance genes and the expected sizes of amplicon.
Target Primer name Primers (5’  3’) Amplicon size (bp) Reference
intI1 I5 (IntI1 F) ACCGCCAACTTTCAGCACAT 930 Di Conza et al., 2002
I3 (IntI1 B) GCGTTCGGTCAAGGTTCTGG
intI2 intI2 F TTATTGCTGGGATTAGGC 223 Goldstein et al., 2001
intI2 R ACGGCTACCCTCTGTTATC
intI3 intI3 F TGTTCTTGTATCGGCAGGTG 600 Goldstein et al., 2001
intI3 R AGTGGGTGGCGAATGAGTG
orf513 341A CGCCCACTCAAACAAACG 468 Sabaté et al., 2002
341B GAGGCTTTGGTGTAACCG
qnrA QnrAm-F AGAGGATTTCTCACGCCAGG 580 Cattoir et al., 2007
QnrAm-R TGCCAGGCACAGATCTTGAC
qnrB QnrBm-F GGMATHGAAATTCGCCACTG 264 Cattoir et al., 2007
QnrBm-R TTTGCYGYYCGCCAGTCGAA
qnrC qnrC-F GGGTTGTACATTTATTGAATC 307 Wang et al., 2009
qnrC-R TCCACTTTACGAGGTTCT
qnrD qnrD-F CGAGATCAATTTACGGGGAATA 581 Covaco et al., 2009
qnrD-R AACAAGCTGAAGCGCCTG
qnrS QnrSm-F GCAAGTTCATTGAACAGGGT 428 Cattoir et al., 2007
QnrSm-R TCTAAACCGTCGAGTTCGGCG
qepA QepA-GF ACATCTACGGCTTCTTCGTCG 502 Rincón et al., 2013
QepA-GR AACTGCTTGAGCCCGTAGATC
aac(6’)-Ib-cr AAC(6’)-F CGATCTCATATCGTCGAGTG 477 Rincón et al., 2013
AAC(6’)-R TTAGGCATCACTGCGTGTTC
blaCMY CITM F TGGCCAGAACTGACAGGCAAA 462 Pérez-Pérez and Hanson, 2002
CITM R TTTCTCCTGAACGTGGCTGGC
blaDHA DHAM F AACTTTCACAGGTGTGCTGGGT 405 Pérez-Pérez and Hanson, 2002
DHAM R CCGTACGCATACTGGCTTTGC
Table 2 - Antibiotic susceptibility profile of 71 studied isolates.
Species Number of resistant isolates (%)
AMP AMS CTN CTX CAZ GEN CIP NIT TMS
E. coli (n = 63) 42 15 13 1 1 7 13 2 20
K. pneumoniae (n = 6) 6 3 3 0 0 3 4 4 3
P. mirabilis (n = 2) 1 0 0 0 0 0 1 2 1
Total (n = 71) 49 (69%) 18 (25%) 16 (22%) 1 (1.4%) 1 (1.4%) 10 (14%) 18 (25%) 8 (11%) 24 (33%)
AMP: ampicillin, AMS: ampicillin/sulbactam, CTN: cephalothin, CTX: cefotaxime, CAZ: ceftazidime, GEN: gentamicin, CIP: ciprofloxacin, NIT: ni-
trofurantoin, TMS: trimethoprim/sulfamethoxazole.
gle isolate showed a second substitution in parC
(Glu84Gly).
The distribution of the phylogenetic groups of the 63
E. coli isolates was 16 A, 11 B1 , 11 B2, and 25 D, showing
a higher percentage of isolates belonging to B2 and D
groups (57%) with respect to those linked to commensal
strains (A and B1 groups: 43%).
When assessing the association between fluoroquino-
lone susceptibility profile and its distribution into the four
phylogenetic groups, a significant difference was observed
(p = 0.0111). Further analysis showed that 10 of 13 fluoro-
quinolones resistant isolates (76.9%) belonged to the
phylogenetic groups, A and B1, while 33 of 50 non-resis-
tant fluoroquinolone isolates (66.0%) belonged to the
groups, B2 and D (p = 0.0100). These results suggest that
fluoroquinolone-susceptible E. coli strains would have
more virulence determinants since they belong to the phy-
logenetic groups, B2 and D. In contrast, there was a strong
association between fluoroquinolone-resistance strains and
A and B1 phylogenetic groups, suggesting that the presence
of these resistance mechanisms would favor E. coli clones
to become successful commensals.
Discussion
As expected, species distribution of Enterobac-
teriaceae showed that E. coli is the predominant bacteria in
cases of UTI (Auer et al., 2010).
The high prevalence (42%) of integrons found in
studied isolates should be considered as a wake-up call, be-
cause of the latent ability of these genetic platforms to re-
cruit novel resistance mechanisms and promote the emer-
gence of multidrug resistant isolates. On the other hand, the
presence of integrons was found to be associated with TMS
resistance, a fact which can be determined by analyzing
3-terminal conserved region of class 1 integrons where the
sul1 gene is commonly located, which confers resistance to
sulfonamides (Di Conza and Gutkind, 2010).
A unique 3GC resistant isolate harboring blaCMY-2
gene was detected among the isolates derived from these
patients. Within AmpCp, this -lactamase is the most
widely distributed in the world and has previously been de-
scribed in UTIs caused by E. coli from outpatients in Ar-
gentina (Cejas et al., 2012).
This study has demonstrated the absence of PMQR
determinants in Enterobacteriaceae causing outpatient
UTIs, regardless of whether these isolates are susceptible or
resistant to fluoroquinolones. Although there are many re-
ports describing the presence of these PMQR determinants
in Argentina (Andres et al., 2013; Rincón et al., 2013;
Rincón et al., 2014), comparisons with our work should be
carefully made due to the difference in criteria of selection
of the bacteria used in these studies. The lack of statistical
association between the presence of integrons and CIP re-
sistance is consistent with the absence of PMQR determi-
nants, particularly of allelic variant aac(6’)-Ib-cr, which
has been described as cassettes in the variable region of
class 1 integrons (Di Conza and Gutkind, 2010).
Interestingly, in this work, a strong association be-
tween fluoroquinolone-resistant E. coli and A and B1 phy-
logenetic groups (considered commensal) was observed.
Other studies have shown that acquisition of resistance de-
terminants and the expression of a multidrug resistance
phenotype is associated with a decrease in virulence of E.
coli isolates (Molina-López, 2011). Furthermore, some evi-
dences suggest that quinolones resistance in E. coli may be
associated with the loss of certain virulence factors such as
expression of -hemolysis and P fimbriae, a condition that
can be attributed to a decrease in the activities of gyrase and
topoisomerase due to mutations in the QRDR region re-
sponsible for resistance to these antibiotics (Drews et al.,
2005).
In conclusion, this study reports a detailed character-
ization of uropathogenic Enterobacteriaceae isolates de-
rived from outpatients in Santa Fe city, Argentina. The
highest degrees of resistance were observed for AMP, TMS
and CIP. A high percentage of integrons (42%) was also de-
tected. The ability of these genetic platforms to recruit anti-
biotic resistance cassettes efficiently is a potential threat to
the emergence of multidrug-resistant isolates. In particular,
all uropathogenic E. coli isolated did not show PMQR de-
terminants, and mutations in QRDR regions were observed
in those fluoroquinolone-resistant isolates.
Moreover, marked differences between fluoroquino-
lone-susceptible profile and phylogenetic groups in E. coli
strains were observed. A subsequent analysis showed a cor-
relation between fluoroquinolone resistant isolates and
phylogenetic groups considered potentially less virulent (A
and B1), and vice versa. Finally, periodic surveillance stud-
ies are recommended to review the use of -lactams, fluo-
roquinolones, and TMS while choosing empirical
treatment for UTIs.
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